Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Eve & Co Inc V.EVE.H

Eve & Co Incorporated is a Canada-based company, which holds cultivation and processing licenses for the production and sale of various cannabis products, including dried cannabis, cannabis plants and extraction of cannabis oil. It is a licensed producer of medicinal marijuana. It also provides educational information and online support for its customers and first-time buyers. Its products include The Boss Bath Bomb, The Dreamer Bath Bomb, The Lover Bath Bomb, The Optimist CBD Bath Bomb, Indica Blend, Sativa Blend, The Boss, The Confidant, The Creator, The Lover, The Adventurer, The Advocate, and The Free Spirit. Its wholly owned subsidiary is Natural MedCo Ltd. The Boss Bath Bomb has an invigorating blend of sweet orange, lemon, and grapefruit essential oils that come together to enhance and lift mood, reduce stress, and stimulate circulation. The Dreamer Bath Bomb has calming lavender and chamomile essential oils that help to reduce stress and anxiety and promote calmness.


TSXV:EVE.H - Post by User

Comment by stwatcheron Jun 16, 2020 11:39am
278 Views
Post# 31155806

RE:RE:mmj news release

RE:RE:mmj news release

Netherlands apparently limiting number of German cannabis clients

The Dutch government agency responsible for exporting medical cannabis exports is reportedly limiting, for now, the number of German wholesalers it ships to.

Berlin-based AMP German Cannabis Group said in a news release the Dutch Office of Medicinal Cannabis (OMC) “has postponed selling EU-(Good Manufacturing Practice) medical cannabis to additional importers, including AMP, until further notice.”

 

MJBizConNEXT Direct
AMP said it “placed its first order to import two Bedrocan International-branded products from OMC, which subsequently confirmed receipt of AMP’s order.” But the German company did not directly state whether the order was shipped.

 

Marijuana Business Daily confirmed with a handful of German wholesalers that the quantity of Dutch cannabis each was getting for delivery in June was up to 5 kilograms, the same quantity each was able to order in May.

That suggests the OMC is not accepting new German importers.

Every month, the OMC ships about 200 kilograms (441 pounds) to Germany as part of a 2,500-kilograms-per-year supply agreement between the Dutch and German governments.

The constant amount of Dutch-produced cannabis combined with a growing number of German importers has resulted in each importer receiving less every month.

In April, the OMC’s approximately 30 German wholesaler clients received up to 6.5 kilograms each.

In May, the number of clients increased to 40 and the amount per client decreased to up to 5 kilograms.

If each importer is again being able to get up to 5 kilograms in June, it means the OMC limited the number of German clients at around 40 companies.

AMP said it is negotiating with “several” federally licensed producers in Canada to start commercial shipments later this year.

The “first large imports of AMP’s medical cannabis brand are expected to be coming from Canada during the fall of 2020 from licensed producers that were EU-GMP certified prior to COVID-19 pandemic,” according to another news release from the Berlin company.

In 2019, almost 40% of the medical cannabis flower imported to be sold to patients in Germany came from the Netherlands, with the rest mostly coming from Canada and a small portion from Portugal.

<< Previous
Bullboard Posts
Next >>